Human Liver Model Market Size, Share, Trends Analysis, And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Human Liver Model Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.79 billion In 2028 At A CAGR Of 12.9%.
The human liver model market size has grown rapidly in recent years. It will grow from $2.07 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to drug development needs, advancements in biotechnology, animal testing alternatives, rising liver diseases, regulatory demands.

The human liver model market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to ai and machine learning integration, patient-derived liver models, bioengineering breakthroughs, drug safety and toxicity testing requirements, virtual clinical trials. Major trends in the forecast period include multi-organ models integration, 3d bioprinting innovations, high-throughput screening capability, enhanced vascularization and blood flow, ethical and regulatory compliance.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp

Human Liver Model Market Major Segments
The human liver model market covered in this report is segmented -
1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, Animal Models, 3D Bioprinting
2) By Application: Educational, Drug Discovery, Other Applications
3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users

Key Driver - Rising Incidence Of Liver Disease Drives Growth In The Human Liver Model Market

The rising cases of liver disease are expected to propel the growth of the human liver model market going forward. Liver disease refers to any disorder of the liver that can stop the liver from working or prevent it from functioning well. The use of human liver models is an emerging area of research that has the potential to improve the understanding of liver diseases and drug development. Hence, the rising cases of liver diseases are propelling the growth of the human liver model market. For instance, in September 2022, according to Caner Australia, an Australia-based government cancer agency, around 2,905 new cases of liver cancer were diagnosed in Australia in 2022 (2,113 males and 792 females). Further, the risk of developing liver cancer by age 85 is predicted to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. Therefore, the rising cases of liver disease are propelling the human liver model market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12244&type=smp

Prominent Trend - Product Innovation In The Human Liver Model Market

Product innovation has emerged as a key trend gaining popularity in the human liver model market. Major companies operating in the human liver model market are concentrating on creating innovative products to strengthen their position in the market. For instance, in April 2023, LifeNet Health Life Sciences, a US-based human cell and tissue-based solution provider launched TruVivo, a ground-breaking liver system made entirely of human cells that will aid in the crucial research and development of new drugs and compounds. This innovative 2D+ solution combines the robust data that goes with 3D models with the flexibility and simplicity of a 2D model.

Human Liver Model Market Players
Major companies operating in the human liver model market report are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Strand Life Sciences Pvt Ltd., Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, Ascendance Biotechnology Inc., HemoShear Therapeutics Inc., Cyfuse Biomedical KK, Cyfuse Biomedical, MIMETAS BV, Bio Innovations, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the human liver model market in 2023. The regions covered in the human liver model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Human Liver Model Market Report Structure
3. Human Liver Model Market Trends And Strategies
4. Human Liver Model Market - Macro Economic Scenario
5. Human Liver Model Market Size And Growth
…..
27. Human Liver Model Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.